Rashmi Bansal, PhDProfessor of Neuroscience
|
Education
Degree | Institution | Major |
---|---|---|
BS | Lucknow University | Biology |
MS | Lucknow University | Biochemistry |
PhD | Central Drug Research Institute | Neuroscience |
Name & Description | Category | Role | Type | Scope | Start Year | End Year |
---|---|---|---|---|---|---|
European Glia Meeting, Porto, Portugal | Workshop/Conference | Symposium Organizer | External | International | 2019 | |
American Society for Neurochemistry | Professional/Scientific Organization | Committee Member | External | National | 2011 | |
American Society for Neurochemistry | Professional/Scientific Organization | Session Chair Organizer | External | National | 2011 | |
Asia-Pacific Society for Neurochemistry, | Professional/Scientific Organization | Committee Member | External | International | 2010 | |
Asian-Pacific Society for Neurochemistry. | Professional/Scientific Organization | Symposium Chair | External | International | 2010 | |
Abimbola Sunmonu, Genetics and Developmental Biology Program (Ph.D.) | Other | Committee member | UConn Health | University | 2010 | |
Shahana Abdullah, Neuroscience Program (Ph.D.) | Other | Committee member | UConn Health | University | 2010 | |
Nominating Committee | Advisory Committee | Member | UConn Health | University | 2009 | |
Curriculum Committee | Education Committee | Member | UConn Health | University | 2009 | |
Site Visit to Shriners supported research center | Research Committee | Committee Member | External | National | 2009 | |
Myelin Satellite Conference, International Society for Neurochemistry | Professional/Scientific Organization | Committee Member | External | International | 2009 | |
American Society for Neurochemistry | Professional/Scientific Organization | Council Member | External | National | 2009 | 2011 |
Satellite Conference on Myelin Biology, International Society for Neurochemistry | Professional/Scientific Organization | Invited Session Chair | External | International | 2009 | |
International Society for Neurochemistry. New perspectives for signaling in oligodendrocyte development | Professional/Scientific Organization | Symposium Chair | External | International | 2009 | |
American Society for Neurochemistry. Fibroblast growth factor function in neural development and disease | Professional/Scientific Organization | Symposium Co-Chair | External | National | 2009 | |
Journal of Neuroscience Research, Special Issue on Myelin | Editorial Board | Co-Editor | External | National | 2009 | |
Erin Boisvert, Genetics and Developmental Biology Program (Ph.D.) | Other | Committee member | UConn Health | University | 2009 | |
Katerina Ikonomu, Neuroscience Program (Ph.D.) | Other | Committee member | UConn Health | University | 2009 | |
Asia-Pacific Society for Neurochemistry | Professional/Scientific Organization | Council Member | External | International | 2008 | 2012 |
Indian Academy for Neuroscience. Regulation of oligodendrocyte development and myelination | Professional/Scientific Organization | Symposium Chair | External | International | 2008 | |
National Institute of Health, Cellular Molecular Biology of Glia Study Section | Study Section | Regular Member | External | National | 2008 | 2012 |
Melissa Bryant, Univ. of Hartford (M.S.) | Other | Committee member | External | University | 2008 | 2010 |
Organizer of Neuroscience Department Seminars | Advisory Committee | Member | UConn Health | University | 2007 | |
Student Progress Committee Member | Education Committee | Member | UConn Health | University | 2007 | |
Myelin Satellite Conference, International Society for Neurochemistry | Professional/Scientific Organization | Committee Member | External | International | 2007 | |
Kroc-UConn Health Center Symposia on “Myelin Biology and Demyelinating Diseases”. | Advisory Committee | Organizer | UConn Health | University | 2007 | |
Satellite Conference on Myelin Biology, International Society for Neurochemistry | Professional/Scientific Organization | Session Chair | External | International | 2007 | |
Journal of Neuroscience Research | Editorial Board | Associate Editor | External | National | 2007 | |
Presidential Advisory Committee, American Society for Neurochemistry. | Professional/Scientific Organization | Appointed member | External | National | 2006 | 2007 |
Special Neurochemistry Conference of International Society for Neurochemistry on “Neural Glycomics and Lipidomics | Professional/Scientific Organization | Host Liason | External | International | 2006 | |
International Society for Neurochemistry Neural Glycomics and Lipidomics | Professional/Scientific Organization | Symposium Chair | External | International | 2006 | |
Asian-Pacific Society for Neurochemistry. Regulation of Oligodendrocyte Development and Differentiation | Professional/Scientific Organization | Symposium Chair | External | International | 2006 | |
Gordon Research Conference on Myelin | Professional/Scientific Organization | Discussion Leader | External | National | 2006 | |
Multiple Sclerosis Society of Canada | Study Section | Ad hoc member | External | International | 2006 | |
Multiple Sclerosis Society of France | Study Section | Ad hoc member | External | International | 2006 | |
Cheryl Habrukowich, Cell Biology Program 2006 (Ph.D.) | Other | Committee member | UConn Health | University | 2006 | 2006 |
Committee on Aid and Education of the International Society for Neurochemistry | Professional/Scientific Organization | Appointed member | External | International | 2005 | 2008 |
International Society for Neurochemistry.New Frontiers in Lipid Biology | Professional/Scientific Organization | Symposium Chair | External | International | 2005 | |
Multiple Sclerosis Society of USA | Study Section | Ad hoc member | External | National | 2005 | |
Publicity, Public Policy and Education Committee, American Society for Neurochemistry. | Professional/Scientific Organization | Appointed member | External | National | 2004 | 2008 |
International Society of Developmental Neuroscience | Professional/Scientific Organization | Committee Member | External | International | 2004 | |
American Society for Neurochemistry.FGF old molecules, new tricks | Professional/Scientific Organization | Symposium Chair | External | National | 2004 | |
International Society for Developmental Neuroscience. Control of oligodendrocyte development | Professional/Scientific Organization | Symposium Chair | External | International | 2004 | |
National Institute of Health Study Section, Neurogenesis and Cell Fate | Study Section | Ad hoc member | External | National | 2004 | |
Katie Stockdale, Univ. of Hartford (M.S.) | Other | Committee member | External | University | 2004 | 2007 |
Medical School Council | Advisory Committee | Member | UConn Health | University | 2003 | 2005 |
Research Subcommittee of the Medical School Council | Research Committee | Member | UConn Health | University | 2003 | 2005 |
Myelin Satellite Conference Organization Committee, International Society for Neurochemistry | Professional/Scientific Organization | Co-Chair | External | International | 2003 | |
VI Kroc-UConn Conference on Myelin Biology and Demyelinating Diseases | Professional/Scientific Organization | Committee Member | UConn Health | University | 2003 | |
International Society for Neurochemistry. | Professional/Scientific Organization | Colloquium Chair | External | International | 2003 | |
American Society for Neurochemistry. FGF in Development | Professional/Scientific Organization | Symposium Co-Chair | External | National | 2003 | |
Dental School Council | Advisory Committee | Member | UConn Health | University | 2002 | 2005 |
XVII International Symposium on Glycoconjugates. Gangliosides in neuronal functions and cellular signaling | Professional/Scientific Organization | Session Chair | External | International | 2002 | |
American Society for Neurochemistry. Regulation of Oligodendrocyte Development | Professional/Scientific Organization | Symposium Chair | External | National | 2002 | |
Gordon Research Conference on Myelin. Signaling and Cell Cycle in Myelinating Cells | Professional/Scientific Organization | Discussion Leader | External | National | 2002 | |
Journal of Postgraduate Medicine | Editorial Board | External | National | 2002 | ||
First year Ph.D Student Advisory Committee | Advisory Committee | Member | UConn Health | University | 2001 | |
International Society for Neurochemistry. Regulation of neural signal transduction in glycosphingolipid-cholesterol microdomains | Professional/Scientific Organization | Symposium Chair | External | International | 2001 | |
Developmental Neuroscience | Editorial Board | External | National | 2001 | ||
Journal of Neuroscience Research | Editorial Board | External | National | 2001 | ||
Department of Neuroscience Faculty Search Committee | Advisory Committee | Member | UConn Health | University | 2000 | 2002 |
Neuroscience Program Admissions Committee | Education Committee | Member | UConn Health | University | 2000 | |
UConn. Medical School and Graduate School student inteviewer | Education Committee | Member | UConn Health | University | 2000 | |
International Journal of Developmental Neuroscience | Editorial Board | External | International | 2000 | 2010 | |
Chris Taylor, Neuroscience Program (Ph.D.) | Other | Committee member | UConn Health | University | 2000 | 2005 |
Young Investigators Educational Enhancement Committee, American Society for Neurochemistry. | Professional/Scientific Organization | Committee member | External | National | 1999 | 2002 |
American Society for Neurochemistry. Glycosphingolipids in development and disease | Professional/Scientific Organization | Symposium Co-Chair | External | National | 1999 | |
International Society of Pharmacology. Myelin biology and demyelinating diseases | Professional/Scientific Organization | Symposium Chair | External | International | 1999 | |
International Society for Developmental Neuroscience. FGF regulation of neural development | Professional/Scientific Organization | Symposium Chair | External | International | 1998 | |
International Society of Neurochemistry, Myelin Satellite organizing and local host committees | Professional/Scientific Organization | Committee member | External | International | 1997 | |
Kroc-UConn Health Center, Neurology Symposia, organizing committee | Professional/Scientific Organization | Committee member | UConn Health | University | 1997 | |
Sheila Bheddah, Univ. of Hartford (M.S.) | Other | Committee member | External | University | 1997 | 1999 |
Brain Bouverat, Neuroscience Program (M.S.) | Other | Committee member | UConn Health | University | 1996 | 1999 |
Young Investigators Educational Enhancement Committee, American Society for Neurochemistry. | Professional/Scientific Organization | Committee member | External | National | 1995 | 1997 |
Kroc-UConn Health Center, Neurology Symposia, organizing committee | Professional/Scientific Organization | Committee member | UConn Health | University | 1995 | |
Inter-American Cooperation Committee, American Society for Neurochemistry. | Professional/Scientific Organization | Committee member | External | National | 1993 | 1995 |
Multiple Sclerosis Society of Great Britain and Northern Ireland. | Study Section | Ad hoc member | External | International | ||
United States-Israel Binational Science Foundation, Israel. | Study Section | Ad hoc member | External | International | ||
Veterans Administration Grant, USA. | Study Section | Ad hoc member | External | National | ||
Group of Women in Medicine and Science (GWIMS)of AAMC | Professional/Scientific Organization | Member | UConn Health | University | ||
Neuroscience Department Seminar series | Professional/Scientific Organization | Organizer | UConn Health | University | ||
International Journal for Developmental Neuroscience | Editorial Board | Member | External | International |
Developmental, cellular and molecular biology of Oligodendrocytes, the cells that synthesize myelin membrane in the central nervous system; growth factor regulation of development and function and its relationship to neurodegenerative disease, including Multiple Sclerosis.Current research is focused on investigation of basic mechanisms of cell biology in a developmental context. (oligodendrocyte developmental lineage is the model system)--Molecular mechanisms of regulation of differentiation by growth factor receptors, including the application of transgenic mouse models, cell culture and transfection systems.
--Membrane biogenesis and function, including the role of glycosphingolipid-cholesterol microdomains (rafts) and signal transduction.
--The relationship of these to Multiple Sclerosis
--Membrane biogenesis and function, including the role of glycosphingolipid-cholesterol microdomains (rafts) and signal transduction.
--The relationship of these to Multiple Sclerosis
Not accepting lab rotation students at this time
Journal Articles
-
Mek/ERK1/2-MAPK and PI3K/Akt/mTOR signaling plays both independent and cooperative roles in Schwann cell differentiation, myelination and dysmyelination.
Glia, 69:2429-2446 2021 Jun;
-
Developmental stage-specific role of Frs adapters as mediators of FGF receptor signaling in the oligodendrocyte lineage cells.
Glia 2020 Mar;68(3):617-630
-
Corrigendum: Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy.
Human molecular genetics 2019 Jul;28(13):2282
-
Independent and cooperative roles of the Mek/ERK1/2-MAPK and PI3K/Akt/mTOR pathways during developmental myelination and in adulthood.
Glia 2019 Feb;67(7):1277-1295
-
Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy.
Human molecular genetics 2019 Jan;
-
Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy.
Human molecular genetics 2018 Dec;
-
Conditional knockout of TOG results in CNS hypomyelination.
Glia 2017 Mar;65(3):489-501
-
Signaling by FGF-Receptor-2, not FGF-Receptor-1, Regulates Myelin Thickness Through Activation of ERK1/2-MAPK, Which Promotes mTORC1 Activity in an Akt-Independent Manner.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2017 Feb;372931-2946
-
Strength of ERK1/2 MAPK Activation Determines Its Effect on Myelin and Axonal Integrity in the Adult CNS.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2016 Jun;36(24):6471-87
-
Renal 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase Is an Important Determinant of AKI Severity after Ischemia-Reperfusion.
Journal of the American Society of Nephrology : JASN 2015 Nov;272069-81
-
Fibroblast growth factor signaling in oligodendrocyte-lineage cells facilitates recovery of chronically demyelinated lesions but is redundant in acute lesions.
Glia 2015 Oct;63(10):1714-28
-
Role of 2',3'-cyclic nucleotide 3'-phosphodiesterase in the renal 2',3'-cAMP-adenosine pathway.
American journal of physiology. Renal physiology 2014 Jul;307(1):F14-24
-
Treatment with thyroxine restores myelination and clinical recovery after intraventricular hemorrhage.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2013 Oct;33(44):17232-46
-
The antiaging protein Klotho enhances oligodendrocyte maturation and myelination of the CNS.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2013 Jan;33(5):1927-39
-
The brain in vivo expresses the 2',3'-cAMP-adenosine pathway.
Journal of neurochemistry 2012 Jul;122(1):115-25
-
ERK1/ERK2 MAPK signaling is required to increase myelin thickness independent of oligodendrocyte differentiation and initiation of myelination.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2012 Jun;32(26):8855-64
-
Fibroblast growth factor receptor signaling in oligodendrocytes regulates myelin sheath thickness.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2012 May;32(19):6631-41
-
Erk1/2 MAPK and mTOR signaling sequentially regulates progression through distinct stages of oligodendrocyte differentiation.
Glia 2012 Mar;60(3):476-86
-
Bone morphogenetic protein inhibition promotes neurological recovery after intraventricular hemorrhage.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2011 Aug;31(34):12068-82
-
Fibroblast growth factor signaling is required for the generation of oligodendrocyte progenitors from the embryonic forebrain.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2011 Mar;31(13):5055-66
-
Acquired Gitelman's syndrome: an oxymoron?
International urology and nephrology 2011 Mar;43(1):233-6
-
Myelin protein composition is altered in mice lacking either sulfated or both sulfated and non-sulfated galactolipids.
Journal of neurochemistry 2010 Feb;112(3):599-610
-
Inactivation of fibroblast growth factor receptor signaling in myelinating glial cells results in significant loss of adult spiral ganglion neurons accompanied by age-related hearing impairment.
Journal of neuroscience research 2009 Nov;87(15):3428-37
-
Human myelin proteome and comparative analysis with mouse myelin.
Proceedings of the National Academy of Sciences of the United States of America 2009 Aug;106(34):14605-10
-
Phosphorylation and lipid raft association of fibroblast growth factor receptor-2 in oligodendrocytes.
Glia 2009 Jul;57(9):935-46
-
Disruption of fibroblast growth factor receptor signaling in nonmyelinating Schwann cells causes sensory axonal neuropathy and impairment of thermal pain sensitivity.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2009 Feb;29(6):1608-14
-
Role for Rab3a in oligodendrocyte morphological differentiation.
Journal of neuroscience research 2009 Feb;87(2):342-52
-
Microglial Fc receptors mediate physiological changes resulting from antibody cross-linking of myelin oligodendrocyte glycoprotein.
Journal of neuroimmunology 2008 May;196(1-2):35-40
-
Dysplasia and malignancy in endocervical polyps.
Journal of women's health (2002) 2007 Nov;16(9):1317-21
-
Mice with conditional inactivation of fibroblast growth factor receptor-2 signaling in oligodendrocytes have normal myelin but display dramatic hyperactivity when combined with Cnp1 inactivation.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2006 Nov;26(47):12339-50
-
Induction of oligodendrocyte progenitors in dorsal forebrain by intraventricular microinjection of FGF-2.
Developmental biology 2006 Sep;297(1):262-73
-
A role for Sec8 in oligodendrocyte morphological differentiation.
Journal of cell science 2006 Mar;119(Pt 5):807-18
-
Distinct fibroblast growth factor (FGF)/FGF receptor signaling pairs initiate diverse cellular responses in the oligodendrocyte lineage.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005 Aug;25(32):7470-9
-
S-phase entry of oligodendrocyte lineage cells is associated with increased levels of p21Cip1.
Journal of neuroscience research 2005 May;80(3):360-8
-
CNP is required for maintenance of axon-glia interactions at nodes of Ranvier in the CNS.
Glia 2005 Apr;50(1):86-90
-
Signaling cascades activated upon antibody cross-linking of myelin oligodendrocyte glycoprotein: potential implications for multiple sclerosis.
The Journal of biological chemistry 2005 Mar;280(10):8985-93
-
Does paranode formation and maintenance require partitioning of neurofascin 155 into lipid rafts?
The Journal of neuroscience : the official journal of the Society for Neuroscience 2004 Mar;24(13):3176-85
-
Myelin associated glycoprotein cross-linking triggers its partitioning into lipid rafts, specific signaling events and cytoskeletal rearrangements in oligodendrocytes.
Neuron glia biology 2004 Feb;1(1):35-46
-
Sulfatide is a negative regulator of oligodendrocyte differentiation: development in sulfatide-null mice.
Glia 2004 Feb;45(3):269-77
-
Specific inhibitor of FGF receptor signaling: FGF-2-mediated effects on proliferation, differentiation, and MAPK activation are inhibited by PD173074 in oligodendrocyte-lineage cells.
Journal of neuroscience research 2003 Nov;74(4):486-93
-
Paranodal transverse bands are required for maintenance but not initiation of Nav1.6 sodium channel clustering in CNS optic nerve axons.
Glia 2003 Nov;44(2):173-82
-
The myelin-axolemmal complex: biochemical dissection and the role of galactosphingolipids.
Journal of neurochemistry 2003 Nov;87(4):995-1009
-
Antibody cross-linking of myelin oligodendrocyte glycoprotein leads to its rapid repartitioning into detergent-insoluble fractions, and altered protein phosphorylation and cell morphology.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003 Jul;23(13):5461-71
-
Fibroblast growth factor receptor 3 signaling regulates the onset of oligodendrocyte terminal differentiation.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003 Feb;23(3):883-94
-
Expression of FGF receptors 1, 2, 3 in the embryonic and postnatal mouse brain compared with Pdgfralpha, Olig2 and Plp/dm20: implications for oligodendrocyte development.
Developmental neuroscience 2003 Jan;25(2-4):83-95
-
Syndecan-3 and perlecan are differentially expressed by progenitors and mature oligodendrocytes and accumulate in the extracellular matrix.
Journal of neuroscience research 2002 Aug;69(4):477-87
-
PDGF and FGF-2 signaling in oligodendrocyte progenitor cells: regulation of proliferation and differentiation by multiple intracellular signaling pathways.
Molecular and cellular neurosciences 2000 Mar;15(3):314-29
-
Expression of rab GTP-binding proteins during oligodendrocyte differentiation in culture.
Journal of neuroscience research 2000 Feb;59(3):446-53
-
Negative regulation of oligodendrocyte differentiation by galactosphingolipids.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1999 Sep;19(18):7913-24
-
FGF-2 converts mature oligodendrocytes to a novel phenotype.
Journal of neuroscience research 1997 Oct;50(2):215-28
-
Regulation of oligodendrocyte differentiation by fibroblast growth factors.
Advances in experimental medicine and biology 1997 Jan;42969-77
-
Developmental and FGF-2-mediated regulation of syndecans (1-4) and glypican in oligodendrocytes.
Molecular and cellular neurosciences 1996 Apr;7(4):276-88
-
Regulation of FGF receptors in the oligodendrocyte lineage.
Molecular and cellular neurosciences 1996 Apr;7(4):263-75
-
Monoclonal autoantibody SCH94.03, which promotes central nervous system remyelination, recognizes an antigen on the surface of oligodendrocytes.
Journal of neuroscience research 1996 Feb;43(3):273-281
-
Early development and dispersal of oligodendrocyte precursors in the embryonic chick spinal cord.
Development (Cambridge, England) 1995 Jun;121(6):1743-54
-
Regulation of gene expression in mature oligodendrocytes by the specialized myelin-like membrane environment: antibody perturbation in culture with the monoclonal antibody R-mAb.
Glia 1994 Nov;12(3):173-9
-
Inhibition of protein and lipid sulfation in oligodendrocytes blocks biological responses to FGF-2 and retards cytoarchitectural maturation, but not developmental lineage progression.
Developmental biology 1994 Apr;162(2):511-24
-
The oligodendrocyte and its many cellular processes
Trends in Cell Biology 1993 Jan;3(6):191-197
-
Novel stage in the oligodendrocyte lineage defined by reactivity of progenitors with R-mAb prior to O1 anti-galactocerebroside.
Journal of neuroscience research 1992 Jul;32(3):309-16
-
Proligodendroblast antigen (POA), a developmental antigen expressed by A007/O4-positive oligodendrocyte progenitors prior to the appearance of sulfatide and galactocerebroside.
Journal of neurochemistry 1992 Jun;58(6):2221-9
-
Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development.
Journal of neuroscience research 1989 Dec;24(4):548-57
-
Reversible inhibition of oligodendrocyte progenitor differentiation by a monoclonal antibody against surface galactolipids.
Proceedings of the National Academy of Sciences of the United States of America 1989 Aug;86(16):6181-5
-
Stimulation of oligodendrocyte differentiation in culture by growth in the presence of a monoclonal antibody to sulfated glycolipid.
Journal of neuroscience research 1988 Jan;21(2-4):260-7
-
Regulated galactolipid synthesis and cell surface expression in Schwann cell line D6P2T.
Journal of neurochemistry 1987 Dec;49(6):1902-11
-
Developmental expression of 2',3'-cyclic nucleotide 3'-phosphohydrolase in dissociated fetal rat brain cultures and rat brain.
Journal of neuroscience research 1985 Jan;14(1):21-34
-
Effect of copper T and Lippe's loop on Catalase activity of human endometrium.
Indian J Med Res 1980 Jan;7266-70
-
Comparative effects of intrauterine copper and nylon contraceptive devices on biochemical constituents of rat uterus and fallopian tube.
Indian journal of experimental biology 1976 Jul;14(4):476-8
-
Effect of intrauterine contraceptive copper and nylon devices on the ionic constituents of the rat uterus.
Indian J Expt Biol 1976 Jan;14475-476
-
Effect of a copper intrauterine contraceptive device on enzyme activity of the rat endometrium.
Contraception 1972 Jan;6459-464
-
-
Sustained activation of ERK1/2 MAPK in Schwann cells causes corneal neurofibroma.
Journal of Neuroscience Research 95(9):1712-1729
Book Chapters
-
Functional Dynamics of Myelin Lipids
Handbook of Neurochemistry and Molecular Neurobiology 2009 Jan;
-
NEPHGE and pI strip proteomic two-dimensional gel electrophoretic mapping of lipid-rich membranes
The Proteomics Protocols Handbook 2005 Jan;
-
The Transport, Assembly, and Function of Myelin Lipids
Myelin and its Diseases 2003 Jan;57-80
-
Mechanisms of myelin membrane biogenesis by oligodendrocytes.
Frontiers of Neural Development 1998 Jan;
-
Regulation of oligodendrocyte differentiation by fibroblast growth factors
Brain Plasticity: Development and Aging 1997 Jan;
-
Oligodendrocyte progenitor development: Reversible inhibition by a monoclonal antibody reacting with galactocerebroside and sulfatide
Differentiation and Function of Glia 1990 Jan;159-168
-
Regulation of oligodendrocyte progenitor development: antibody perturbation studies
Cellular and Molecular Biology of Myelination, NATO ASI Series 1990 Jan;19-31
-
Trophic regulation of myelinogenesis
Trophic Factors in the Nervous System 1989 Jan;247-261
-
Oligodendrocyte differentiation: Quantitative studies in primary cultures of dissociated fetal rat brain
Glial-Neuronal Communication in Development and Regeneration, 1986 Jan;737-754
-
Regulation of early myelinogenesis in primary cultures of dissociated rat brain
Neuroscience Approached Through Cell Culture. Vol. II. 1983 Jan;167-176
Conference Papers
-
Characterization of monoclonal antibodies O1, O4, and R-mAb used in the anaysis of oligodendrocyte development
Annals of the New York Academy of Sciences 1990 Jan;605409-411
Reviews
-
Oligodendrocyte development and myelin biogenesis: parsing out the roles of glycosphingolipids.
Physiology (Bethesda, Md.) 2009 Oct;24(5):290-7
-
Fibroblast growth factors and their receptors in oligodendrocyte development: implications for demyelination and remyelination.
Developmental neuroscience 2002 Jan;24(1):35-46
Title or Abstract | Type | Sponsor/Event | Date/Year | Location |
---|---|---|---|---|
Integration of growth factor signaling in the regulation of developmental myelination and in the adult CNS | Talk | Europe Glia Meeting | 2019 | Porto, Portugal |
Role of FGF-ERK signaling in the regulation of myelination | Talk | International symposium of myelin in health and disease | 2019 | Hangzhou, China |
Membrane Domains in CNS Physiology and Pathology | Talk | 4th Special International Society for Neurochemistry | 2010 | Sicily, Italy. |
Signaling to and by myelin forming cells | Talk | Gordon Research Conference on Myelin Biology | 2004 | Barga, Italy |
Positive and negative regulators of oligodendrocyte terminal differentiation | Talk | Department of Neuroscience, Case Western Reserve University | 2003 | Cleveland, OH |
Sulfated Galactsylceramide regulates oligodendrocyte differentiation and myelin-axolemmal interaction | Talk | Second Charleston Ceramide Conference | 2003 | Como, Italy |
Regulation of Oligodendrocyte Terminal Differentiation: Analysis of Genetically Modified Mice | Talk | Department of Neuroscience, University of Connecticut Health Center | 2003 | Farmington, CT |
Role of glycosphingolipids in oligodendrocyte differentiation and myelin biogenesis | Talk | Gordon Research Conference on Glycolipid and Sphingolipid Biology | 2002 | Ventura, CA |
Fibroblast growth factor receptor-3 null mice exhibit a delay in the development of oligodendrocytes and myelination | Talk | American Society for Neurochemistry | 2002 | West Palm Beach, Florida |
Syndecan-3 and perlican are differentially synthesized by progenitor and mature oligodendrocyte and accumulates in the ECM | Talk | International Society for Neurochemistry Satellite Meeting on Myelin Biology | 2001 | Colonia, Uraguay |
Is sulfatide the glycosphingolipid molecule responsible for negatively regulating oligodendrocyte differentiation and normal myelin formation | Talk | International Society for Neurochemistry Satellite Meeting on Glycosphingolipids | 2001 | Iguazu, Argentina |
FGF receptors in oligodendrocyte development | Talk | Department of Biological Sciences, Tata Institute of Fundamental Research | 2001 | Mumbai, India |
FGF receptor function in oligodendrocyte development | Talk | Gordon Research Conference on Myelin Biology | 2000 | Barga, Italy |
Negative regulation of oligodendrocyte differentiation by galactosphingolipids | Talk | Gordon Research Conference on Glycolipid and Sphingolipid Biology | 2000 | Barga, Italy |
FGFs in development and disease | Talk | Department of Neuroscience, University of Connecticut Health Center | 2000 | Farmington, CT |
Regulation of oligodendrocyte differentiation and myelin biogenesis | Talk | University of Cambridge | 1999 | Cambridge, UK |
Re-programming of differentiation fate: FGF-2 converts mature oligodendrocytes to a novel dedifferentiated stage | Talk | King's College | 1999 | London, UK. |
Demyelinating diseases and mice mutants of myelin genes | Talk | International Society for Pharmacology | 1999 | New Delhi, India |
Negative regulation of oligodendrocyte differentiation by galactolipids | Talk | International Society for Neurochemistry Satellite Meeting on Myelin Biology | 1999 | Ruegen, Germany |
Developmental and ligand-mediated regulation of FGF- receptors and co-receptors during oligodendrocyte differentiation and de-differentiation | Talk | Conference of Indian Academy of Neuroscience and National Symposium on Signal Transduction | 1998 | New Delhi, India |
Regulation of oligodendrocyte development by Fibroblast growth factors: Lineage stage-specific modulation of receptor expression | Talk | International Society for Developmental Neuroscience | 1998 | Vancouver, Canada |
FGF receptor and Co-receptor expression and regulation in the oligodendrocyte lineage | Talk | Penn State College of Medicine | 1998 | Hershey, PA |
Importance of glycolipids in oligodendrocyte membrane biogenesis and maintenance: Protein lipid interactions | Talk | International Society for Neurochemistry | 1997 | Boston, MA |
Altered oligodendrocyte differentiation in mice lacking Galactocerebroside and Sulfatide | Talk | Interntational Society for Neurochemistry Satellite Meeting | 1997 | Mystic, CT |
Regulation of cell differentiation by environmental factors | Talk | Eighth Medical Symposium | 1997 | Ross University School of Medicine, Dominica |
Requirement of cell surface heparan sulfate for response of oligodendrocyte progenitors to FGF | Talk | Boeringer Ingleheim | 1997 | Ridgefield, CT |
Oligodendrocyte development and regulation by growth factors | Talk | Hopital de la Salpetriere | 1996 | Paris, France |
Regulation of oligodendrocyte development by FGF | Talk | Gordon Research Conference on Myelin | 1996 | Barga, Italy |
FGF-2 stimulates mature oligodendrocyte process outgrowth | Talk | American Society for Neurochemistry | 1996 | Philadelphia, PA |
Changing repertoire of FGF receptors and putative co-receptors during oligodendrocyte development: Regulation by ligand | Talk | International Society for Neurochemistry Myelin Satellite | 1995 | Okazaki, Japan |
Role of sulfatide in oligodendrocyte development and myelin biogenesis | Talk | International Society for Neurochemistry | 1995 | Kyoto, Japan |
FGF Co-receptor, Syndecan-3 is expressed and required for Oligodendrocyte progenitor proliferation | Talk | Gordon Research Conference on Myelin | 1994 | Ventura, CA |
Oligodendrocyte developmental regulation: Growth factors and cell surface molecules | Talk | Elba International Neuroscience Program Summer School | 1993 | Elba, Italy |
N-Syndecan is developmentally regulated during oligodendrocyte differentiation, and may act as a putative low affinity bFGF receptor on Pro-oligodendroblasts | Talk | International Society for Neurochemistry Myelin Satellite | 1993 | La Londe, France |
Sulfatide synthesis is not a pre-requisite for oligodendrocyte lineage progression | Talk | International Society for Neurochemistry | 1993 | Montpellier, France |
Analysis of the oligodendrocyte cell lineage in culture and in vivo | Talk | New York Friends of Myelin Group | 1992 | Hunter Collage, NY, NY |
POA, a developmental antigen expressed by A007/O4 positive oligodendrocyte progenitors prior to the appearance of sulfatide | Talk | International Society for Neurochemistry Myelin Satellite | 1991 | Fiji Islands |
Regulation of gene expression in mature oligodendrocytes by the specialized myelin-like membrane environment | Talk | Kroc-UConn Symposium. UConn Health Center | 1990 | Farmington, CT |
Myelinogenesis: perturbation by antibodies to oligodendrocyte lineage cell surface components | Talk | Symposium on "Differentiation and Function of Glia" | 1989 | Rome, Italy |